9 October 2013 - Deborah Wilkes
Archived
Atrium said the purchase price of US$15.9 million represented a multiple of 4.75-times Mucos' Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) over the past 12 months.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.